publication date: Jun. 20, 2014


Briefs.html

In Brief
Patricia LoRusso Named Associate Director Of Innovative Medicine at Yale Cancer Center


PATRICIA LORUSSO was named associate director of innovative medicine at Yale Cancer Center. She will take the job in August, and will also serve as a professor of medicine.

Prior to her appointment at Yale, she served in numerous leadership roles at Wayne State University’s Barbara Karmanos Cancer Institute, most recently as director of the Phase I Clinical Trials Program and of the Eisenberg Center for Experimental Therapeutics.

LoRusso has served as co-chair of the NCI Cancer Therapy Evaluation Program Investigational Drug Steering Committee. She also served on the scientific committee of the American Association for Cancer Research, and the education and scientific committees of the American Society of Clinical Oncology.

She is a former editor of Investigational New Drugs, is currently on the editorial board for Clinical Cancer Research, and is a reviewer for several journals.

She has garnered numerous awards, including the 1999 Heroes of Breast Cancer Award; 2004 Bennett J. Cohen Educational Leadership Award for Medical Research, 2008 NCI Michaele C. Christian Oncology Development Lectureship and Award; the 2014 Targeted Anticancer Therapies Honorary Award; and will receive the 2014 Michigan State University Distinguished Alumni Award.


CORINNE AUGELLI-SZAFRAN
was named director of chemistry at Southern Research Institute.

She will be responsible for managing the institute’s chemical research initiatives in oncology, infectious diseases and neuroscience.

Most recently, Augelli-Szafran was the director of the Laboratory for Experimental Alzheimer Drugs at Harvard Medical … Continue reading 40-25 In Brief: LoRusso Moves to Yale Cancer Center

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.